Conferoport

Conferoport (Tacrolimus) is an oral medication used to suppress the immune system. It is commonly prescribed for organ transplant patients to prevent rejection. This medication is manufactured by Sandoz S.P.A. in the EU.

Conferoport is primarily used to prevent organ rejection in transplant patients. It works by suppressing the immune system to reduce the risk of the body attacking the new organ. This medication may also be used for other conditions as determined by a healthcare provider.

Common effects of Conferoport may include headaches, tremors, and increased blood pressure. Some users might experience gastrointestinal issues such as nausea or diarrhea. It is important to monitor for any unusual symptoms and consult a healthcare provider if they persist.

Conferoport should be handled with care and stored as directed. It is essential to follow the prescribed dosage and administration instructions. Patients should avoid activities that require alertness until they know how the medication affects them.

Conferoport may interact with other medications, including certain antibiotics, antifungals, and antivirals. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol should be avoided as it may exacerbate side effects.